{"entity":{"id":"nct04365374","kind":"trial","name":"Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)","aka":[],"tldr":"A phase 3 trial of Gamma Tile-Surgically Targeted Radiation Therapy (STaRT) in brain and spinal cord tumours, run by GT Medical Technologies, Inc., active and no longer recruiting.","summary":"Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study) is a phase 3 interventional study registered as NCT04365374 by GT Medical Technologies, Inc., with 230 participants enrolled, started 2021-04-06 and due to reach its primary completion in 2029-08-30. Interventions recorded: Gamma Tile-Surgically Targeted Radiation Therapy (STaRT) and Stereotactic Radiation Therapy.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT04365374","url":"https://clinicaltrials.gov/study/NCT04365374"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["brain-tumours"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["gt-medical-technologies"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT04365374","phase":"3","setting":"A Phase 3 Randomized Controlled Trial of Post-Surgical Stereotactic Radiotherapy (SRT) Versus Surgically Targeted Radiation Therapy (STaRT) With Gamma Tile for Treatment of Newly Diagnosed Metastatic Brain Tumors.","sponsor":"GT Medical Technologies, Inc.","enrolled":230,"outcomes":[]},"route":"/trials/nct04365374/","neighbours":{"cancer":[{"id":"brain-tumours","kind":"cancer","name":"Brain and spinal cord tumours (all types)","route":"/cancers/brain-tumours/"}],"company":[{"id":"gt-medical-technologies","kind":"company","name":"GT Medical Technologies","route":"/companies/gt-medical-technologies/"}]}}